Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)

Authors

Ruth Dobson, Queen Mary University of London
Matthew Craner, Frimley Health NHS Foundation Trust
Ed Waddingham, Imperial College London
Aleisha Miller, Imperial College London
Jayant Pindoria, Imperial College London
Ana Cavey, John Radcliffe Hospital
Camilla Blain, St George's Hospital
Luca G De
Nikos Evangelou, Nottingham University Hospitals NHS Trust
Helen Ford, Leeds Teaching Hospitals NHS Trust
Paul Gallagher, Queen Elizabeth University Hospital, Glasgow
Katila George, Queen Mary University of London
Ramos Dias R Geraldes
Paula Harman, Southend Hospital
Jeremy Hobart, Peninsula Medical School
Tanya King, University Hospitals Plymouth NHS Trust
Ruth Linighan, John Radcliffe Hospital
Niall MacDougall, Institute of Neurological Sciences
Monica Marta, Royal London Hospital
Stephanie Mitchell, Northern Care Alliance NHS Group
Richard Nicholas, Charing Cross Hospital
David Rog, Northern Care Alliance NHS Group
Antonio Scalfari, Charing Cross Hospital
Neil Scolding, Southmead Hospital NHS Trust
Stewart Webb, Queen Elizabeth University Hospital, Glasgow
Sarah White, St George's Hospital
Judith Wilton, Frimley Health NHS Foundation Trust
Carolyn Young, The Walton Centre NHS Foundation Trust
Paul M. Matthews, Imperial College London

ORCID

• Jeremy Hobart: 0000-0002-2114-7920

DOI

10.1016/j.msard.2022.103894

Publication Date

2022-01-01

Publication Title

Multiple Sclerosis and Related Disorders

Volume

63

ISSN

2211-0348

Embargo Period

2022-07-02

Recommended Citation

Dobson, R., Craner, M., Waddingham, E., Miller, A., Pindoria, J., Cavey, A., Blain, C., De, L., Evangelou, N., Ford, H., Gallagher, P., George, K., Geraldes, R., Harman, P., Hobart, J., King, T., Linighan, R., MacDougall, N., Marta, M., Mitchell, S., Nicholas, R., Rog, D., Scalfari, A., Scolding, N., Webb, S., White, S., Wilton, J., Young, C., & Matthews, P. (2022) 'Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)', Multiple Sclerosis and Related Disorders, 63. Available at: 10.1016/j.msard.2022.103894